- Record: found
- Abstract: found
- Article: not found
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
R J Barst
1 ,
L J Rubin ,
W A Long ,
M D McGoon ,
S Rich ,
D B Badesch ,
B M Groves ,
V F Tapson ,
R C Bourge ,
B H Brundage ,
S K Koerner ,
D Langleben ,
C A Keller ,
S Murali ,
B F Uretsky ,
L M Clayton ,
M M Jöbsis ,
S D Blackburn ,
D Shortino ,
J W Crow
Feb 01 1996
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Primary pulmonary hypertension is a progressive disease for which no treatment has been shown in a prospective, randomized trial to improve survival.
Related collections
Author and article information
Comments
Comment on this article
scite_